Arabinogalactan for hepatic drug delivery

Area of Science:

• Biochemistry
• Pharmacology
• Natural Products

Background:

• Arabinogalactan is a polysaccharide isolated from the Western Larch tree (Larix occidentalis).
• Its biological and physical characteristics are not fully elucidated.
• Potential applications in drug delivery warrant investigation.

Purpose of the Study:

• To characterize the physical and biological properties of arabinogalactan.
• To evaluate its suitability as a carrier for diagnostic or therapeutic agents.
• To assess its targeting potential to hepatocytes via the asialoglycoprotein receptor.

Main Methods:

• Purification and characterization of arabinogalactan.
• Radiolabeling and intravenous injection in animal models (rats, mice).
• Assessment of hepatic uptake, distribution, and clearance using radioactivity measurements.
• Gel chromatography, light scattering, glycosyl linkage analysis, and NMR spectroscopy for structural determination.
• Acute and sub-chronic toxicity studies.

Main Results:

• Arabinogalactan demonstrated significant hepatic uptake (52.5% of dose) in rats, reducible by asialofetuin.
• Structural analysis revealed a highly branched galactopyranose backbone.
• Molecular weight estimates varied (19 kDa by gel chromatography, 40 kDa by light scattering).
• No adverse reactions were observed in toxicity studies.
• Radioactivity cleared from the liver with a half-life of 3.42 days.

Conclusions:

• Arabinogalactan is a safe polysaccharide with properties suitable for hepatocyte targeting.
• Its ability to interact with the asialoglycoprotein receptor makes it a promising carrier for liver-directed therapies.
• Further research into its drug delivery capabilities is justified.